Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial
View Full Paper
Ask AI
Bookmark
Share
No abstract yet
We only have this paper's title and publication details.